Adoption of Double Chamber Prefilled Syringes Market to Increase During COVID-19

Posted by Merin John on May 19th, 2021

The Double Chamber Prefilled Syringes Market report tabled by Persistence Market Research focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain – right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare.

Persistence Market Research (PMR), in its new offering, opines global double chamber prefilled syringes market to grow at a CAGR of 9% during the forecast period. Over the recent years, FDA has approved a large number of parenteral drugs for lyophilized products, which is boosting the requirement for parenteral drug delivery systems of higher efficiency. This is among the major factors boosting the global demand for dual and multi-chamber prefilled syringes.

The efficacy of constituted drugs is majorly influenced by drug delivery systems. Owing to their limitations, traditional modes are likely to impact the overall drug delivery process, however, dual chamber syringe technology ensures highly efficient drug use through precise product constitution.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/29257

Company Profiles:

Pfizer Inc.

Biosciences, Inc.

Ypsomed AG

Otsuka America Pharmaceutical, Inc.

Credence MedSystems, Inc.

Vetter Pharma International GmbH

MAEDA INDUSTRY Co., Ltd.

AstraZeneca plc

AbbVie Inc.

Nipro Corporation

SCHOTT AG

Dual chamber syringes are specifically designed for the administration of highly sensitive drugs (protein, probiotics, etc.), as well as to maintain their desired shelf life. The actual active ingredient of the drug is lyophilized in one of the two chambers of the syringe, and the other chamber of the prefilled syringe contains a solvent that mixes with active substances immediately before their application.

According to PMR, the global double chamber prefilled syringes market is estimated to have accounted for approximately US$ 1.4 Bn in terms of value in 2018. High convenience associated with the usage of double chamber prefilled syringes is driving their adoption among end users, which is boosting the demand for double chamber prefilled syringes.

This is one of the leading factors that are significantly contributing to the growth of the double chamber prefilled syringes market. Moreover, double chamber prefilled syringes facilitate next-generation drug delivery technology and are more patient-centric as compared to traditional modes.

Like it? Share it!


Merin John

About the Author

Merin John
Joined: December 11th, 2020
Articles Posted: 262

More by this author